Single-arm phase II study of consolidation serplulimab following hypofractionated radiotherapy with concurrent chemotherapy for patients with limited stage small-cell lung cancer: ASTRUM-LC01 study protocol

Single-arm phase II study of consolidation serplulimab following hypofractionated radiotherapy with concurrent chemotherapy for patients with limited stage small-cell lung cancer: ASTRUM-LC01 study protocol

Introduction With the inspiring results of the PACIFIC trial in non-small-cell lung cancer (NSCLC), and the CAPIAN and IMpower133 trials in extensive-stage small-cell lung cancer (SCLC), immunotherapy has increasingly gained attention. Serplulimab, a PD-1 inhibitor, showed great antitumour activity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tao Zhang, Jianchun Duan, Xiaohong Zhou, Jianzhong Cao, Yuqi Wu, Jianyang Wang, Nan Bi, Lei Deng
Format: Artikel
Sprache:Englisch
Veröffentlicht: BMJ Publishing Group 2025-05-01
Schriftenreihe:BMJ Open
Online-Zugang:https://bmjopen.bmj.com/content/15/5/e085552.full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Login für die Nachverfolgung von Bestellungen und Vormerkungen

Online

https://bmjopen.bmj.com/content/15/5/e085552.full

Ähnliche Einträge